Sophie Broutin
Institut Gustave Roussy(FR)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Inflammation biomarkers and pathways, Cancer, Hypoxia, and Metabolism, Autoimmune and Inflammatory Disorders Research, Testicular diseases and treatments
Most-Cited Works
- → AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations(2017)450 cited
- → Crizotinib-induced immunogenic cell death in non-small cell lung cancer(2019)290 cited
- → SomaticRASMutations Occur in a Large Proportion of SporadicRET-Negative Medullary Thyroid Carcinomas and Extend to a Previously Unidentified Exon(2012)149 cited
- → The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development(2016)116 cited
- → Body Composition Variation and Impact of Low Skeletal Muscle Mass in Patients With Advanced Medullary Thyroid Carcinoma Treated With Vandetanib: Results From a Placebo-Controlled Study(2013)99 cited
- → Pharmacokinetic Behavior and Appraisal of Intravenous Busulfan Dosing in Infants and Older Children(2012)80 cited
- → Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 2, immune checkpoint inhibitor antibodies(2020)75 cited
- → Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 1, monoclonal antibodies, antibody-drug conjugates and bispecific T-cell engagers(2020)54 cited
- → Comparative transplacental transfer of taxanes using the human perfused cotyledon placental model(2012)43 cited
- → Identification of Soluble Candidate Biomarkers of Therapeutic Response to Sunitinib in Medullary Thyroid Carcinoma in Preclinical Models(2011)39 cited